Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of Sofosbuvir & Daclatasvir Combined Therapy for Treatment of Egyptian Children and Adolescents With Chronic Hepatitis C (HCV)-Genotype 4

NCT03080415 is registered in ClinicalTrials.gov with Yassin Abdelghaffar Charity Center for Liver Disease and Research as lead sponsor.

NCT NCT03080415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03080415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of Sofosbuvir & Daclatasvir Combined Therapy for Treatment of Egyptian Children and Adolescents With Chronic Hepatitis C (HCV)-Genotype 4
Lead sponsor
Yassin Abdelghaffar Charity Center for Liver Disease and Research
Phase
Phase 3
Overall status
Completed
Start date
March 18, 2017
Completion date
May 18, 2018
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c genotype 4